InvestorsHub Logo
Followers 64
Posts 24020
Boards Moderated 0
Alias Born 11/23/2016

Re: falconer66a post# 182684

Friday, 02/22/2019 5:32:15 PM

Friday, February 22, 2019 5:32:15 PM

Post# of 464792

All this fits with Missling’s recent statement of the company’s intent to conduct clinical trials with Anavex 3-71. No indication yet for which diseases or conditions.


Pretty sure it will be Frontal Lobe Dementia (FTD) for which A3-71 has Orphan Dug Designation.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146674591
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News